Time.com shares the story about a patient who was treated using brain cancer immunotherapy. One year after the treatment, he is still alive and well. Using this kind of therapy is quickly becoming popular in terms of dealing with tumors.
Promising results are associated mostly with blood cancers like lymphomas and leukemias. The therapy has yet to prove its capabilities in treating other solid tumors like breast, prostate, lung and colon cancers.
Experimental Brain Cancer Treatment Is a Success
But in a report published in the New England Journal of Medicine, researchers led by Dr. Behnam Badie from the City of Hope Beckman Research Institute and Medical Center say that the same immune-based therapy that is successful against blood cancers also helped a patient with advanced brain cancer. Read more…
The researchers used CAR-T therapy, and the results were promising. Glioblastoma is considered to be a critical condition as it is one of the deadliest cancers. This is a kind of disease that responds to very limited treatment options. Most of the time, the outcome is poor.
However, a single case study may give cancer specialists a new approach on how to handle the therapy for this disease. CAR-T treatment has been deemed as controversial and has had some issues during the clinical trials. However, in this case, it has shown a lot of progress in solid tumor cancers.
CAR-T Therapy Makes Early Inroads In Treating Brain Cancer
Researchers at the City of Hope cancer treatment center in the Los Angeles Area tested a CAR-T therapy out on a 50-year-old man with recurrent multifocal glioblastoma — that is, several tumors growing in tandem in his brain. He had failed all other available treatments. Read more…
Gizmodo shares the story of the patient. The researchers from City of Hope Beckman Research Institute paved way for the revolutionary new therapy to potentially treat brain cancer. The 50-year old patient has recurring multifocal glioblastoma, and things were starting to get difficult for him.
The disease is known for being so aggressive and unresponsive to treatments. The patient enrolled him in a clinical trial for CAR-T. Seven-and-a-half months later, the results were simply astounding.
New Cancer Therapy Shows Promise in Treating Aggressive Brain Tumors
Seven-and-a-half months later, the patient’s tumor had shrunk to virtually nothing, and he went into remission. Had the patient not received the experimental treatment, his doctors say he would have likely died by now. Read more…
The development of this treatment is going to be a huge breakthrough for oncology. Hopefully, with more trials and research, there will be progress in the case.
The post The Success Of Experimental Brain Cancer Treatments appeared first on NUTRITION CLUB CANADA.
No comments:
Post a Comment